{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:09:18Z","timestamp":1784545758929,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/igo\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Americas"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.lana.2022.100235","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T05:01:10Z","timestamp":1648443670000},"page":"100235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Achieving high immunogenicity against poliovirus with fractional doses of inactivated poliovirus vaccine in Ecuador-results from a cross-sectional serological survey"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2617-9021","authenticated-orcid":false,"given":"Gabriel","family":"Trueba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishali","family":"Jeyaseelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lazaro","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo A.","family":"Mainou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Whittembury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo Jose Olmedo","family":"Valarezo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Baquero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Romero","family":"de Aguinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia Jeannete Zurita","family":"Salinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Gabriela Santacruz","family":"Mancheno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana Elizabeth Medina","family":"Chacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Quentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Elena","family":"Chevez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Rey-Benito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Mach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lana.2022.100235_bib0001","doi-asserted-by":"crossref","first-page":"S281","DOI":"10.1093\/infdis\/175.Supplement_1.S281","article-title":"Certification of the eradication of indigenous transmission of wild poliovirus in the Americas","volume":"175","author":"Robbins","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lana.2022.100235_bib0002","unstructured":"Cases of Wild Poliovirus by country and year: Online Reference Table. Retrieved 10\/02\/2022, from http:\/\/www.polioeradication.org\/Dataandmonitoring\/Poliothisweek\/Wildpolioviruslist.aspx."},{"issue":"9","key":"10.1016\/j.lana.2022.100235_bib0003","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1128\/JVI.02954-12","article-title":"Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria","volume":"87","author":"Burns","year":"2013","journal-title":"J Virol"},{"issue":"20","key":"10.1016\/j.lana.2022.100235_bib0004","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1016\/j.vaccine.2009.02.071","article-title":"Vaccine-derived poliovirus (VDPV): impact on poliomyelitis eradication","volume":"27","author":"Minor","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.lana.2022.100235_bib0005","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","article-title":"Vaccine-derived polioviruses and the endgame strategy for global polio eradication","volume":"59","author":"Kew","year":"2005","journal-title":"Ann Rev Microbiol"},{"issue":"5566","key":"10.1016\/j.lana.2022.100235_bib0006","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1126\/science.1068284","article-title":"Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus","volume":"296","author":"Kew","year":"2002","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.lana.2022.100235_bib0007","first-page":"242","article-title":"Update on vaccine-derived polioviruses-worldwide","volume":"63","author":"Diop","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.lana.2022.100235_bib0008","first-page":"741","article-title":"Update on vaccine-derived polioviruses-worldwide","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.lana.2022.100235_bib0009","doi-asserted-by":"crossref","first-page":"S434","DOI":"10.1093\/infdis\/jiu222","article-title":"The new polio eradication end game: rationale and supporting evidence","volume":"210","author":"Sutter","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lana.2022.100235_bib0010","series-title":"Global Switch in Oral Polio Vaccines","year":"2016"},{"issue":"35","key":"10.1016\/j.lana.2022.100235_bib0011","doi-asserted-by":"crossref","first-page":"934","DOI":"10.15585\/mmwr.mm6535a3","article-title":"Cessation of trivalent oral poliovirus vaccine and introduction of inactivated poliovirus vaccine - worldwide, 2016","volume":"65","author":"Hampton","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6489","key":"10.1016\/j.lana.2022.100235_bib0012","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1126\/science.aba1238","article-title":"Evolving epidemiology of poliovirus serotype 2 following withdrawal of the type 2 oral poliovirus vaccine","volume":"368","author":"Macklin","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.lana.2022.100235_bib0013","unstructured":"Ecuador MoH. Immunization schedule 2019. Retrieved 09\/09\/2021, from: https:\/\/www.salud.gob.ec\/wp-content\/uploads\/2020\/01\/ESQUEMA-DE-VACUNACIO%CC%81N.DIC_.2019.ok_.pdf."},{"key":"10.1016\/j.lana.2022.100235_bib0014","unstructured":"Meeting of the Strategic Advisory Group of Experts on immunization, November 2013\u2014conclusions and recommendations. Wkly Epidemiol Rec. 2014;89(1):1\u201320. Retrieved from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24466571"},{"issue":"10040","key":"10.1016\/j.lana.2022.100235_bib0015","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0140-6736(16)00703-0","article-title":"Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial","volume":"388","author":"Asturias","year":"2016","journal-title":"Lancet"},{"issue":"10011","key":"10.1016\/j.lana.2022.100235_bib0016","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/S0140-6736(15)00237-8","article-title":"Immunogenicity of a new routine vaccination schedule for global poliomyelitis prevention: an open-label, randomised controlled trial","volume":"386","author":"Sutter","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.lana.2022.100235_bib0017","series-title":"Summary of the April 2017 Meeting of the Strategic Advisory Group of Experts on Immunization","year":"2017"},{"issue":"22","key":"10.1016\/j.lana.2022.100235_bib0018","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1016\/j.vaccine.2017.03.008","article-title":"Immunogenicity to poliovirus type 2 following two doses of fractional intradermal inactivated poliovirus vaccine: A novel dose sparing immunization schedule","volume":"35","author":"Anand","year":"2017","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.lana.2022.100235_bib0019","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.vaccine.2014.11.025","article-title":"Immune responses after fractional doses of inactivated poliovirus vaccine using newly developed intradermal jet injectors: a randomized controlled trial in Cuba","volume":"33","author":"Resik","year":"2015","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.lana.2022.100235_bib0020","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.vaccine.2011.11.018","article-title":"Intradermal fractional dose inactivated polio vaccine: a review of the literature","volume":"30","author":"Nelson","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.lana.2022.100235_bib0021","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1016\/j.ijid.2011.10.002","article-title":"Randomized controlled study of fractional doses of inactivated poliovirus vaccine administered intradermally with a needle in the Philippines","volume":"16","author":"Cadorna-Carlos","year":"2012","journal-title":"Int J Infect Dis"},{"issue":"9","key":"10.1016\/j.lana.2022.100235_bib0022","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1086\/651611","article-title":"Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in Cuba","volume":"201","author":"Resik","year":"2010","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.lana.2022.100235_bib0023","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4103\/2224-3151.239418","article-title":"National introduction of fractional-dose inactivated polio vaccine in Sri Lanka following the global \u201cswitch\u201d","volume":"7","author":"Gamage","year":"2018","journal-title":"WHO South East Asia J Public Health"},{"issue":"34","key":"10.1016\/j.lana.2022.100235_bib0024","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1016\/j.vaccine.2012.11.021","article-title":"Intradermal delivery for vaccine dose sparing: overview of current issues","volume":"31","author":"Zehrung","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.lana.2022.100235_bib0025","unstructured":"UNICEF, WHO Publication (2021). Poliomyelitis Vaccination Coverage, Ecuador. Retrieved 10\/09\/2021, https:\/\/immunizationdata.who.int\/pages\/coverage\/pol.html?CODE=ECU&ANTIGEN=&YEAR=."},{"key":"10.1016\/j.lana.2022.100235_bib0026","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-4939-3292-4_8","article-title":"Standardized methods for detection of poliovirus antibodies","volume":"1387","author":"Weldon","year":"2016","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.lana.2022.100235_bib0027","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1749-6632.1995.tb44462.x","article-title":"Defining surrogate serologic tests with respect to predicting protective vaccine efficacy: poliovirus vaccination","volume":"754","author":"Sutter","year":"1995","journal-title":"Ann NY Acad Sci"},{"issue":"4","key":"10.1016\/j.lana.2022.100235_bib0028","doi-asserted-by":"crossref","first-page":"699","DOI":"10.17843\/rpmesp.2017.344.3208","article-title":"Diagnosis of anemia in populations at high altitudes","volume":"34","author":"Gonzales","year":"2017","journal-title":"Rev Peru Med Exp Salud Publica"},{"key":"10.1016\/j.lana.2022.100235_bib0029","unstructured":"Foundation, R. (2020). The R Project for Statistical Computing. Retrieved 14\/03\/2022, https:\/\/www.r-project.org\/."},{"issue":"48","key":"10.1016\/j.lana.2022.100235_bib0030","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.1016\/j.vaccine.2015.09.039","article-title":"Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trial","volume":"33","author":"Anand","year":"2015","journal-title":"Vaccine"},{"issue":"25","key":"10.1016\/j.lana.2022.100235_bib0031","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1056\/NEJMoa0909383","article-title":"Fractional doses of inactivated poliovirus vaccine in Oman","volume":"362","author":"Mohammed","year":"2010","journal-title":"N Engl J Med"},{"issue":"10191","key":"10.1016\/j.lana.2022.100235_bib0032","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1016\/S0140-6736(19)30503-3","article-title":"Immunogenicity of full and fractional dose of inactivated poliovirus vaccine for use in routine immunisation and outbreak response: an open-label, randomised controlled trial","volume":"393","author":"Snider","year":"2019","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.lana.2022.100235_bib0033","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1093\/infdis\/jiaa504","article-title":"One-year decline of poliovirus antibodies following fractional-dose inactivated poliovirus vaccine","volume":"223","author":"Saleem","year":"2021","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.lana.2022.100235_bib0034","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1086\/427810","article-title":"Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion","volume":"191","author":"Abbink","year":"2005","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.lana.2022.100235_bib0035","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJM200009143431103","article-title":"Trial of a supplemental dose of four poliovirus vaccines","volume":"343","author":"Sutter","year":"2000","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.lana.2022.100235_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0092-1157(84)80015-3","article-title":"The trend of acquired immunity with live poliovirus vaccine and the effect of revaccination: follow-up of vaccinees for ten years","volume":"12","author":"Nishio","year":"1984","journal-title":"J Biol Stand"}],"container-title":["The Lancet Regional Health - Americas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X22000527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X22000527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T07:52:59Z","timestamp":1757404379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667193X22000527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":36,"alternative-id":["S2667193X22000527"],"URL":"https:\/\/doi.org\/10.1016\/j.lana.2022.100235","relation":{},"ISSN":["2667-193X"],"issn-type":[{"value":"2667-193X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Achieving high immunogenicity against poliovirus with fractional doses of inactivated poliovirus vaccine in Ecuador-results from a cross-sectional serological survey","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Americas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lana.2022.100235","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 World Health Organization. Published by Elsevier Ltd","name":"copyright","label":"Copyright"}],"article-number":"100235"}}